A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 21 Dec 2020

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

28 Oct 2020 Results assessing efficacy of Plecanatide from 4 phase 3 trials presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2020
22 Oct 2014 Results presented at the 79th Annual Scientific Meeting of the American College of Gastroenterology.
21 Oct 2014 As per the media release issued in October 2014, the company has successfully completed an end-of-phase 2 meeting with the FDA for this trial.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com